Similar articles

• Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.

  Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M. Chrzanowska M, et al. Acta Pol Pharm. 2012 May-Jun;69(3):405-10. Acta Pol Pharm. 2012. PMID: 22594254
• Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.

  Brouwer C, Keizer-Garritsen JJ, Lambooy LH, Ament K, Ter Riet PG, De Abreu RA, Bökkerink JP, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ, Trijbels JP. Brouwer C, et al. Adv Exp Med Biol. 2000;486:327-31. doi: 10.1007/0-306-46843-3_63. Adv Exp Med Biol. 2000. PMID: 11783509 No abstract available.
• Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.

  Lennard L, Welch JC, Lilleyman JS. Lennard L, et al. Br J Clin Pharmacol. 1997 Nov;44(5):455-61. doi: 10.1046/j.1365-2125.1997.t01-1-00607.x. Br J Clin Pharmacol. 1997. PMID: 9384462 Free PMC article. Clinical Trial.
• Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.

  Karas-Kuzelicki N, Mlinaric-Rascan I. Karas-Kuzelicki N, et al. Pharmacogenomics. 2009 Aug;10(8):1309-22. doi: 10.2217/pgs.09.78. Pharmacogenomics. 2009. PMID: 19663675 Review.
• The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.

  Coulthard SA, Matheson EC, Hall AG, Hogarth LA. Coulthard SA, et al. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1385-91. doi: 10.1081/NCN-200027637. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571264 Review.